All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

PHARMACOMPASS

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

Product Type

Companies

Neuraxpharm

Virtual Booth Development, Manufacturing & Marketing of Pharmaceuticals for Central Nervous System Pathologies.

SPAIN Spain

Contact Supplier

Virtual Booth

The Boulder Peptide Society

Participation Not Confirmed

Update your events

Panaxia's Agreement with International Pharma Neuraxpharm is Finalized

Lead Product(s): Cannabis products

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: Undisclosed

Highest Development Status: Undisclosed Product Type: Undisclosed

Partner/Sponsor/Collaborator: Panaxia

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement July 22, 2020

Details:

The agreement, which anchors a previous MOU entered by the companies, includes exclusivity for Panaxia products, as well as an option for scaling the distribution to additional countries, also including further major European countries.